A Novel PRPS1 Mutation in a Japanese Patient with CMTX5.


Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
01 Jun 2022
Historique:
pubmed: 23 11 2021
medline: 7 6 2022
entrez: 22 11 2021
Statut: ppublish

Résumé

The PRPS1 gene encodes phosphoribosyl pyrophosphate synthetase 1 (PRS-1). The phenotypes associated with PRPS1 mutations include DFN2 (mild PRS-1 deficiency), X-linked Charcot-Marie-Tooth disease type 5 (CMTX5) (moderate PRS-1 deficiency), Arts syndrome (severe PRS-1 deficiency), and PRS-1 superactivity1. CMTX5 is a very rare hereditary neuropathy characterized by deafness, optic atrophy, and polyneuropathy. We herein report a Japanese patient with CMTX5 who had a novel hemizygous mutation c.82 G>C in PRPS1. Despite showing a typical clinical picture, the decrease in enzyme activity measured in the patient's erythrocytes was milder than in previously reported cases.

Identifiants

pubmed: 34803094
doi: 10.2169/internalmedicine.8029-21
pmc: PMC9259300
doi:

Substances chimiques

PRPS1 protein, human EC 2.7.6.1
Ribose-Phosphate Pyrophosphokinase EC 2.7.6.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1749-1751

Références

Eur J Hum Genet. 2015 Jun;23(6):766-73
pubmed: 25182139
Brain Dev. 2019 Feb;41(2):201-204
pubmed: 30177296
Orphanet J Rare Dis. 2014 Feb 14;9:24
pubmed: 24528855
Orphanet J Rare Dis. 2014 Dec 10;9:190
pubmed: 25491489
Clin Chim Acta. 1994 Jun;227(1-2):79-86
pubmed: 7955424
J Clin Neurol. 2013 Oct;9(4):283-8
pubmed: 24285972
Am J Hum Genet. 2007 Sep;81(3):552-8
pubmed: 17701900

Auteurs

Shunichi Shirakawa (S)

Department of Neurology, Kawasaki Medical School, Japan.

Tatsufumi Murakami (T)

Department of Neurology, Kawasaki Medical School, Japan.

Akihiro Hashiguchi (A)

Department of Neurology and Geriatrics, Kagoshima University, Graduate School of Medical and Dental Sciences, Japan.

Hiroshi Takashima (H)

Department of Neurology and Geriatrics, Kagoshima University, Graduate School of Medical and Dental Sciences, Japan.

Hiroshi Hasegawa (H)

Department of Pathophysiology, Tokyo University of Pharmacy and Life Sciences, School of Pharmacy, Japan.

Kimiyoshi Ichida (K)

Department of Pathophysiology, Tokyo University of Pharmacy and Life Sciences, School of Pharmacy, Japan.

Yoshihide Sunada (Y)

Department of Neurology, Kawasaki Medical School, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH